Beyond Air faces Nasdaq $1 bid-price deficiency
Beyond Air, Inc. has received written notice from Nasdaq that its common stock is not in compliance with the $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2), which is required for continued listing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Beyond Air, Inc. has received written notice from Nasdaq that its common stock is not in compliance with the $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2), which is required for continued listing.
The company has requested a hearing before the Nasdaq Hearings Panel, which has been scheduled for May 14, 2026. This timely request stays any suspension or delisting action until the Panel issues a written decision, so the stock is expected to remain listed on Nasdaq during the hearing process.
The company cautions that there is no assurance the Panel will grant continued listing or that it will regain compliance with Nasdaq’s continued listing standards, and it includes forward-looking statement disclaimers referencing risks described in its Form 10-K and other SEC filings.
Positive
- None.
Negative
- Nasdaq listing at risk: Beyond Air is not in compliance with Nasdaq’s $1.00 bid price requirement under Listing Rule 5550(a)(2), and there is no assurance it will regain compliance or secure continued listing after the Nasdaq Hearings Panel review.
Insights
Nasdaq bid-price noncompliance raises listing risk for Beyond Air.
Beyond Air has fallen below Nasdaq’s $1.00 minimum bid requirement under Listing Rule 5550(a)(2). Nasdaq has issued a deficiency notice and, without relief, the common stock faces potential delisting from the exchange.
The company has requested a hearing before the Nasdaq Hearings Panel, set for May 14, 2026. That request automatically stays suspension or delisting until a written decision is issued, so the shares are expected to remain listed in the meantime.
The company explicitly notes there is no assurance the Panel will grant continued listing or that it will regain compliance with Nasdaq standards. The filing frames these outcomes as forward-looking statements and points investors to existing risk factor disclosures in its Form 10-K and other SEC reports.
8-K Event Classification
Key Figures
Key Terms
Nasdaq Listing Rule 5550(a)(2) regulatory
bid price requirement financial
Nasdaq Hearings Panel regulatory
continued listing standards regulatory
forward-looking statements regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did Beyond Air (XAIR) receive a Nasdaq noncompliance notice?
What steps has Beyond Air (XAIR) taken in response to the Nasdaq notice?
Will Beyond Air (XAIR) be delisted from Nasdaq?
Is Beyond Air’s (XAIR) stock still trading on Nasdaq despite the notice?
AI-generated analysis. How Rhea-AI works. Not financial advice.